Seminars in Radiation Oncology
Volume 17, Issue 3 , Page 157 , July 2007

Introduction

References 

  1. DeVita VT. Hodgkin’s disease—Clinical trials and travails. N Engl J Med. 2003;348:2375–2376
  2. Longo DL. Radiation therapy in Hodgkin disease: Why risk a Pyrrhic victory?. J Natl Cancer Inst. 2005;97:1394–1395
  3. Aviles A, Neri N, Nambo JM, et al. Late cardiac toxicity secondary to treatment in Hodgkin’s disease (A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy). Leuk Lymphoma. 2005;46:1023–1028
  4. Martin WG, Ristow KM, Habermann TM, et al. Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin’s lymphoma. J Clin Oncol. 2005;23:7614–7620
  5. Yahalom J. Don’t throw out the baby with the bathwater: On optimizing cure and reducing toxicity in Hodgkin’s lymphoma. J Clin Oncol. 2006;24:544–548

PII: S1053-4296(07)00021-5

doi: 10.1016/j.semradonc.2007.03.001

Seminars in Radiation Oncology
Volume 17, Issue 3 , Page 157 , July 2007

Article Tools